Apollomics Inc.
APLMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 14 institutions reported holding it in 13F filings for Q2 2026, worth $53.6K in total; no superinvestor holds it.
Other share classesAPLM
Q3 2023 vs. Q2 2023
How the institutions holding Apollomics Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 28 | 28 | 0 |
| Shares | 5.03M | 4.52M | −510.6K (−10.1%) |
| Value | $387.2K | $184.1K | −$203.1K (−52.5%) |
New holders (1)
Institutions that held Apollomics Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 100 | $4 | 0.00% |
Sold out (1)
Institutions that held Apollomics Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jefferies Financial Group Inc. | 392,932 | $33.4K |